NEWS & MEDIA

FDA Approval of Anti-Seizure Drug Provides a New Tool for Protecting Americans During a Chemical Attack
October 24, 2018 — By Judith Laney, Ph.D., Program Manager, Chemical Medical Countermeasures Program, Biomedical Advanced Research and Development Authority, and Lt. Col. Matthew Clark, Joint Product Manager, Chemical Defense Pharmaceuticals, Medical Countermeasure Systems, Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense... MORE

The Food and Drug Administration, in Partnership with the Department of the Army, Accelerated Review and Approval of Life-saving Countermeasure Against Chemical Warfare Agents
July 31, 2018 — THE FOOD AND DRUG ADMINISTRATION, IN PARTNERSHIP WITH THE DEPARTMENT OF THE ARMY, ACCELERATED REVIEW AND APPROVAL OF LIFE-SAVING COUNTERMEASURE AGAINST CHEMICAL WARFARE AGENTS ... MORE

World Health Organization Workshop on Plague Vaccine Evaluation
April 23, 2018 — Dr. Lucy Ward, Senior Scientist for the Joint Vaccine Acquisition Program (JVAP) product management office under the Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) participated in a panel discussion on April 23, 2018 on JVAP's advanced development of a vaccine to protect against plague. The World Health Organization hosted the... MORE

The MCS System NGDS Inc 1 Program Announced as a Finalist in the Medical/Dental Category for the 2018 Edison Awards
February 23, 2018 — FREDERICK, MD, February 5, 2018 – The Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) Next Generation Diagnostic System Increment 1 (NGDS Inc 1) program has been named a finalist in the Medical/Dental category for the 2018 Edison Awards.Established in 1987 and often described as “the Oscars of Innovation,” the Edison... MORE

FilmArray® Community of Interest Biosurveillance Portal: Enhancing Communication Among Users
December 4, 2017 — Across the U.S. Joint Services, there is a continued need for efficient diagnostic equipment that can quickly identify biological warfare agents (BWAs). Diagnostic medical devices are crucial for early diagnosis of exposure to chemical, biological, radiological, and nuclear (CBRN) threats.Furthermore, diagnostics play a critical role in a layered... MORE

MCS Instrumental in EUA Approval of Nerve Agent Autoinjector
November 13, 2017 — ... MORE

MCS Charters New Product Office for Platform Technology Development
November 1, 2017 — FOR IMMEDIATE RELEASE FREDERICK, MD, October 30, 2017 – The Joint Project Management Office for Medical Countermeasure Systems (JPM-MCS) announced the creation of a new office that focuses on developing novel platform technologies to improve Department of Defense efficiencies in medical countermeasure (MCM) development.For years, the... MORE

A Test of Medical Readiness
September 28, 2017 — PREVIOUSLY PUBLISHED IN ONLINE VERSION OF ARMY AL&T MAGAZINE AT (HTTP://ASC.ARMY.MIL/WEB/NEWS-ALT-OND17-A-TEST-FOR-MEDICAL-READINESS/), PRINTED COPY PUBLISHED OCTOBER OF 2017. U.S. military efforts in biological warfare defense readiness prove themselves with Ebola response.The 2014-2016 outbreak of Ebola virus disease triggered an unprecedented... MORE

News Release: Biological Select Agents and Toxins Surrogate Solution
June 19, 2017 — FOR IMMEDIATE RELEASE – FREDERICK, MD. – The Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical and Biological Defense, is pleased to announce the development of a Biological Select Agents and Toxins (BSAT) surrogate solution that will mitigate the risks associated with shipment and... MORE

Nanotherapeutics Opens $138 Million Plant near Progress Park
June 2, 2017 — ALACHUA, FL - Several speakers invoked lessons learned from the Pearl Harbor bombing 75 years ago to the day as they marked the opening of a manufacturing plant that will make vaccines and drug treatments to protect soldiers from chemical and biological threats. About 130 people attended the ribbon-cutting ceremony Wednesday for Nanotherapeutics'... MORE

News Search

News Archive - Search by Year and Month

2026 (10)
2025 (19)
2024 (40)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

CPE CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the CPE CBRND's Capabilities Catalog, Leadership Biographies, and contracting overview documents.

CPE CBRND Public Affairs Office

The CPE CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the CPE CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the CPE CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the CPE CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.